Its announcement arrives about the heels of the same licensing arrangement made available in February to Adastra Labs, which experienced till now centered on crafting cannabis extracts. Adastra's license also will allow it to generate and sell psilocybin and psilocin – hallucinogens far more typically known as magic mushrooms that deliver effects